OmniGen
Commercial- Indications
- Animal nutrition
Company intelligence / Profile preview
Phibro Animal Health markets a broad portfolio of commercialized animal health products including medicated feed additives, antimicrobials, nutritional supplements/minerals and vaccines for food-producing animals. The company has a global presence with over $1 billion in annual sales as of fiscal year ended June 2024. Recent acquisitions have expanded its product range further into medicated feed additives and water-soluble therapeutics[1][10].
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phibro Animal Health.